Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03097744 · ClinicalTrials.gov registry record
Predictors of Early Success From Circumferential Compression STITCH Meniscal Repairs
A clinical trial, sponsored by Smith & Nephew.
- Completed
- Registry status
- 23
- Enrollment target
NCT03097744 is a clinical trial that has completed, run by Smith & Nephew. The registered enrollment target is 23 participants.
The verdict
NCT03097744 has completed, sponsored by Smith & Nephew.
- COMPLETED
- Registry status
- 23 participants
- Enrollment target
Study Summary
This is a retrospective study of meniscal tear repairs at least one-year post repair status. All patients were treated with Ceterix NovoStitch devices. The primary objectives of this study are to assess the clinical repair success rate via reoperation and PROs at greater than 12 months.
Interventions
- DEVICE Ceterix NovoStitch
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2017-02-01 |
| Est. Completion | 2018-04-20 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03097744
The ClinicalTrials.gov registry entry for NCT03097744 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Smith & Nephew, which has 72 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ceterix NovoStitch is the first listed.
NCT03097744 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03097744 about?
NCT03097744 is a clinical study titled "Predictors of Early Success From Circumferential Compression STITCH Meniscal Repairs". This is a retrospective study of meniscal tear repairs at least one-year post repair status. All patients were treated with Ceterix NovoStitch devices. The primary objectives of this study are to assess the clinical repair success rate via reoperation and PROs at greater than 12 months.
What is the current status of trial NCT03097744?
This trial is currently completed. The enrollment target is 23 participants. The study started on 2017-02-01. Estimated completion is 2018-04-20.
What interventions are being tested in trial NCT03097744?
The interventions under investigation include: Ceterix NovoStitch (DEVICE).
Who is sponsoring clinical trial NCT03097744?
This trial is sponsored by Smith & Nephew, which has 72 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.